Severidade das crises epilépticas e qualidade de vida dos pacientes com epilepsia farmacorresistente em uso de dieta cetogênica

Saulo André Benincá, Júlia Dubois Moreira, Letícia Carina Ribeiro da Silva, Débora Kurrle Rieger Venske, Maiara Cristina de Lima, Katia Lin, Mariana dos Santos Lunardi

Resumo


Objetivos: Analisar em uma população de pacientes brasileiros com epilepsia farmacorresistente (EFR) em uso de dieta cetogênica (DC), se a severidade das crises piora a qualidade de vida (QV) dos mesmos. Métodos: Estudo analítico observacional transversal. Dados clínico-demográficos foram obtidos dos pacientes, que responderam aos questionários Global Assessment of Severity of Epilepsy (GASE) e Seizure Severity Questionnaire (SSQ) para aferir a severidade da epilepsia, bem como um inventário para diagnóstico de depressão e ansiedade, a Hospital Anxiety and Depression Scale(HADS-D e HADS-A) e Quality of Life in Epilepsy Inventory-31 (QOLIE-31) para estimar a qualidade de vida.Resultados: Foram entrevistados 10 pacientes, no período de janeiro a setembro de 2019. A média de idade de 34,7 anos, 50% do sexo feminino e média de escolaridade de 11 anos. Os pacientes obtiveram pontuação média de 3,70 na escala GASE, 9,20 na HADS-A, 7,90 na HADS-D e 50,92 na escala QOLIE-31. Houve correlação estatisticamente significante entre as escalas HADS-A e HADS-D (r: 0,886, p=0.001) e entre HADS-A e QOLIE-31 (r: -0,649, p=0.042). Conclusão:A severidade das crises epilépticas em pacientes com EFR em uso de DC não pode ser correlacionada com a QV.


Palavras-chave


Epilepsia; Dieta Cetogênica; Qualidade de vida.

Texto completo:

PDF

Referências


Gagliari RJ, Takayanagui OM. Tratado de Neurologia da Academia Brasileira de Neurologia. 2. ed. Rio de Janeiro: Elsevier, 2019.

Kwan P, Brodie MJ. Effectiveness of First Antiepileptic Drug. Epilepsia. 2001 Oct 29;42(10):1255-60.

Chen Z, Brodie MJ, Liew D, Kwan P. Treatment Outcomes in Patients With Newly Diagnosed Epilepsy Treated With Established and New Antiepileptic Drugs. JAMA Neurol. 2018 Mar 1;75(3):279.

Kwan P, Arzimanoglou A, Berg AT, Brodie MJ, Allen Hauser W, Mathern G, et al. Definition of drug resistant epilepsy: Consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia. 2009 Nov 3;51(6):1069-77.

Nair DR. Management of Drug-Resistant Epilepsy. CONTINUUM: Lifelong Learning in Neurology. 2016 Feb;22(1, Epilepsy):157-72.

Martin K, Jackson CF, Levy RG, Cooper PN. Ketogenic diet and other dietary treatments for epilepsy. Cochrane Database of Systematic Reviews. 2016 Feb 9. Disponível em: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001903.pub3/epdf/full. cesso em: 28 mar. 2021.

Martin-McGill KJ, Bresnahan R, Levy RG, Cooper PN. Ketogenic diets for drug-resistant epilepsy. Cochrane Database of Systematic Reviews. 2020 Jun 24. Disponível em: https://www.cochrane.org/CD001903/EPILEPSY_ketogenic-diets-drug-resistant-epilepsy. Acesso em: 28 mar. 2021.

Teoli D, Bhardwaj,A. Quality Of Life. In: StatPearls. Treasure Island (FL): StatPearls Publishing, 2021.

Baker GA, Nashef L, Hout BA. Current Issues in the Management of Epilepsy: The Impact of Frequent Seizures on Cost of Illness, Quality of Life, and Mortality. Epilepsia. 1997 Jan;38(s1):S1-S8.

Leidy NK, Elixhauser A, Vickrey B, Means E, Willian MK. Seizure frequency and the health-related quality of life of adults with epilepsy. Neurology. 1999 Jul 1;53(1):162.

Silva TId, Alonso NB, Azevedo AM, Westphal-Guitti AC, Migliorini RCVP, Marques CM, et al. Tradução e adaptação cultural da Seizure Severity Questionnaire: resultados preliminares. J epilepsy clin neurophysiol. 2006 Mar;12(1):41-7.

Fisher RS, Acevedo C, Arzimanoglou A, Bogacz A, Cross JH, Elger CE, et al. ILAE Official Report: A practical clinical definition of epilepsy. Epilepsia. 2014 Apr;55(4):475-82.

Cramer JA, Baker GA, Jacoby A. Development of a new seizure severity questionnaire: initial reliability and validity testing. Epilepsy Research. 2002 Feb;48(3):187-97.

Speechley KN, Sang X, Levin S, Zou GY, Eliasziw M, Smith ML, et al. Assessing severity of epilepsy in children: Preliminary evidence of validity and reliability of a single-item scale. Epilepsy & Behavior. 2008 Aug;13(2):337-42.

Cramer JA, Perrine K, Devinsky O, Bryant-Comstock L, Meador K, Hermann B. Development and Cross-Cultural Translations of a 31-Item Quality of Life in Epilepsy Inventory. Epilepsia. 1998 Jan;39(1):81-8.

Botega NJ, Pondé MP, Medeiros P, Lima MG, Guerreiro CAM.Validação da escala hospitalar de ansiedade e depressão (HAD) em pacientes epiléticos ambulatóriais. J. bras. psiquiatr. 1998 Jun;47(6):285–9.

Devinsky O, Penry JK. Quality of Life in Epilepsy: The Clinician's View. Epilepsia. 1993 Sep;34(s4):S4-S7.

Scott AJ, Sharpe L, Hunt C, Gandy M. Anxiety and depressive disorders in people with epilepsy: A meta-analysis. Epilepsia. 2017 Jun;58(6):973-82.

Cramer JA, Blum D, Reed M, Fanning K. The Influence of Comorbid Depression on Seizure Severity. Epilepsia. 2003 Dec;44(12):1578-84.

Tarulli A, Devinsky O, Alper K. Progression of Postictal to Interictal Psychosis. Epilepsia. 2002 Jan 12;42(11):1468-71.

Ridsdale L, Wojewodka G, Robinson E, Landau S, Noble A, Taylor S, et al. Characteristics associated with quality of life among people with drug-resistant epilepsy. J Neurol. 2017 Jun;264(6):1174-84.

Siarava E, Hyphantis T, Katsanos AH, Pelidou S, Kyritsis AP, Markoula S. Depression and quality of life in patients with epilepsy in Northwest Greece. Seizure. 2019 Mar;66:93-8.

Boylan LS, Devinsky O, Barry JJ, Ketter TA. Psychiatric uses of antiepileptic treatments. Epilepsy & Behavior. 2002 Oct;3(5):54-9.

Kwon O, Park S. What is the role of depressive symptoms among other predictors of quality of life in people with well-controlled epilepsy on monotherapy?. Epilepsy & Behavior. 2011 Mar;20(3):528-32.

Norsa’adah B, Zainab J, Knight A. The quality of life of people with epilepsy at a tertiary referral centre in Malaysia. Health and Quality of Life Outcomes. 2013;11(1):143.

Yue L, Yu P, Zhao D, Wu D, Zhu G, Wu X, et al. Determinants of quality of life in people with epilepsy and their gender differences. Epilepsy & Behavior. 2011 Dec;22(4):692-6.

Grant AC, Prus N, Nakhutina L. Factors affecting quality of life in epilepsy in a multi-ethnic urban population. Epilepsy & Behavior. 2013 May;27(2):283-5.

Chandra P, Ahmad F, Tripathi M, Padma M, Gaikwad S, Gupta A, et al. Health-related quality of life using QOLIE-31: Before and after epilepsy surgery a prospective study at a tertiary care center. Neurol India. 2007;55(4):343.

Guekht AB, Mitrokhina TV, Lebedeva AV, Dzugaeva FK, Milchakova LE, Lokshina OB, et al. Factors influencing on quality of life in people with epilepsy. Seizure. 2007 Mar;16(2):128-33.

Bala A, Szantroch M, Gleinert A, Rysz A, Marchel A. Differences in quality of life of women and men with drug-resistant epilepsy in Poland. Epilepsy & Behavior. 2016 Jul;60:94-8.

Gilliam FG, Fessler AJ, Baker G, Vahle V, Carter J, Attarian H. Systematic screening allows reduction of adverse antiepileptic drug effects: A randomized trial. Neurology. 2004 Jan 13;62(1):23-7.

Szaflarski M, Meckler JM, Privitera MD, Szaflarski JP. Quality of life in medication-resistant epilepsy: The effects of patient’s age, age at seizure onset, and disease duration. Epilepsy & Behavior. 2006 May;8(3):547-51.

Jacoby A, Baker GA. Quality-of-life trajectories in epilepsy: A review of the literature. Epilepsy & Behavior. 2008 May;12(4):557-71.




DOI: https://doi.org/10.32963/bcmufsc.v7i3.4910

Apontamentos

  • Não há apontamentos.


Direitos autorais 2021 Saulo André Benincá, Júlia Dubois Moreira, Letícia Carina Ribeiro da Silva, Débora Kurrle Rieger Venske, Maiara Cristina de Lima, Katia Lin, Mariana dos Santos Lunardi

URL da licença: https://creativecommons.org/licenses/by/3.0/